Type 1 Diabetes: Update on Pancreas and Islet Transplantation
Track
:
TRAINEE DAY - Clinical Track/Skills Sessions
Program Code:
090
Date:
Friday, June 18, 2010
Time:
10:05 AM to 10:40 AM
EST
SPEAKER
:
R. Paul Robertson, MD, Pacific Northwest Diabetes Res Inst/Univ of Washington, Seattle, WA Disclosure: Nothing to Disclose
R. Paul Robertson, M.D. is Professor of Medicine and Pharmacology at the University of Washington. He received most of his post-graduate training at the University of Washington where he rose to the rank of Professor of Medicine and Pharmacology in 1980. In 1983 he became Professor of Medicine and Vice-Chair of the Department at the University of Colorado. In 986 he became Professor of Medicine and Cell Biolgy at the University of Minnesota where was recipient of the endowed Pennock Chair in Diabetes Research, Director of the General Clinical Research Center, and Head, Division of Diabetes, Endocrinology, and Nutrition. He has been elected into membership of the American Society for Clinical Investigation and the Association of American Physicians. He was the 2009 President for Medicine and Science of the American Diabetes Association, Editor-in-Chief of Diabetes, the research journal of the American Diabetes Association, a member of the Editorial Board of the Journal of Biological Chemistry and is currently Editor-in-Chief of Endocrine Reviews. Honors that he has received include the endowed Pennock Chair for Diabetes Research at the University of Minnesota; Banting and Best Lecturer at the University of Toronto; Moses Barron Award of the Minnesota Affiliate of the American Diabetes Association; the Albert Renold Award of the American Diabetes Association, and the Banting Medal for Service of the American Diabetes Association. Dr. Robertson has published over 330 manuscripts with primary emphasis on pancreatic islet function in humans, animals and clonal cell lines. His most recent research activities are centered on studies of glucose toxicity and oxidative stress of the beta cell as seen in type 2 diabetic patients. He also studies pancreas and islet transplantation in patients with type 1 diabetes mellitus.